Annual Short Term Debt
$603.00 K
-$824.00 K-57.74%
31 December 2023
Summary:
Brainstorm Cell Therapeutics annual short term debt is currently $603.00 thousand, with the most recent change of -$824.00 thousand (-57.74%) on 31 December 2023. During the last 3 years, it has fallen by -$2.05 million (-77.29%). BCLI annual short term debt is now -77.29% below its all-time high of $2.65 million, reached on 31 December 2020.BCLI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$570.00 K
+$4000.00+0.71%
30 September 2024
Summary:
Brainstorm Cell Therapeutics quarterly short term debt is currently $570.00 thousand, with the most recent change of +$4000.00 (+0.71%) on 30 September 2024. Over the past year, it has dropped by -$736.00 thousand (-56.36%). BCLI quarterly short term debt is now -78.53% below its all-time high of $2.65 million, reached on 31 December 2020.BCLI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.7% | -56.4% |
| 3 y3 years | -77.3% | -67.2% |
| 5 y5 years | +100.0% | - |
BCLI Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.3% | at low | -67.2% | +0.7% |
| 5 y | 5 years | -77.3% | -78.5% | +0.7% | |
| alltime | all time | -77.3% | -78.5% |
Brainstorm Cell Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $570.00 K(+0.7%) |
| June 2024 | - | $566.00 K(-3.7%) |
| Mar 2024 | - | $588.00 K(-2.5%) |
| Dec 2023 | $603.00 K(-57.7%) | $603.00 K(-53.8%) |
| Sept 2023 | - | $1.31 M(-3.5%) |
| June 2023 | - | $1.35 M(-2.5%) |
| Mar 2023 | - | $1.39 M(-2.7%) |
| Dec 2022 | $1.43 M(-2.3%) | $1.43 M(-2.3%) |
| Sept 2022 | - | $1.46 M(-1.2%) |
| June 2022 | - | $1.48 M(-9.3%) |
| Mar 2022 | - | $1.63 M(+11.5%) |
| Dec 2021 | $1.46 M(-45.0%) | $1.46 M(-15.8%) |
| Sept 2021 | - | $1.74 M(-14.8%) |
| June 2021 | - | $2.04 M(-11.4%) |
| Mar 2021 | - | $2.30 M(-13.4%) |
| Dec 2020 | $2.65 M(+110.2%) | $2.65 M(+118.3%) |
| Sept 2020 | - | $1.22 M(-0.7%) |
| June 2020 | - | $1.22 M(+1.3%) |
| Mar 2020 | - | $1.21 M(-4.4%) |
| Dec 2019 | $1.26 M(>+9900.0%) | $1.26 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $137.00 K | $137.00 K(+234.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $41.00 K(+4000.0%) |
| June 2010 | - | $1000.00(-88.9%) |
| Mar 2010 | - | $9000.00(-97.6%) |
| Dec 2009 | $370.00 K(-16.5%) | $370.00 K(+40.2%) |
| Sept 2009 | - | $264.00 K(+28.2%) |
| June 2009 | - | $206.00 K(-50.0%) |
| Mar 2009 | - | $412.00 K(-7.0%) |
| Dec 2008 | $443.00 K(-67.0%) | $443.00 K(-3.9%) |
| Sept 2008 | - | $461.00 K(+5.7%) |
| June 2008 | - | $436.00 K(-68.5%) |
| Mar 2008 | - | $1.39 M(+3.3%) |
| Dec 2007 | $1.34 M(+19.1%) | $1.34 M(+16.2%) |
| Sept 2007 | - | $1.15 M(-37.8%) |
| June 2007 | - | $1.86 M(+21.3%) |
| Mar 2007 | - | $1.53 M(+33.8%) |
| Dec 2006 | $1.13 M(+127.1%) | - |
| Sept 2006 | - | $1.14 M(+19.2%) |
| June 2006 | - | $959.50 K(+93.5%) |
| Mar 2006 | - | $495.90 K(+1499.7%) |
| Mar 2006 | $495.90 K(+2261.4%) | - |
| Dec 2003 | - | $31.00 K(0.0%) |
| Sept 2003 | - | $31.00 K(+47.6%) |
| June 2003 | - | $21.00 K(0.0%) |
| Mar 2003 | $21.00 K(+107.9%) | $21.00 K |
| Mar 2002 | $10.10 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual short term debt?
- What is the all time high annual short term debt for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual short term debt year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly short term debt year-on-year change?
What is Brainstorm Cell Therapeutics annual short term debt?
The current annual short term debt of BCLI is $603.00 K
What is the all time high annual short term debt for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual short term debt is $2.65 M
What is Brainstorm Cell Therapeutics annual short term debt year-on-year change?
Over the past year, BCLI annual short term debt has changed by -$824.00 K (-57.74%)
What is Brainstorm Cell Therapeutics quarterly short term debt?
The current quarterly short term debt of BCLI is $570.00 K
What is the all time high quarterly short term debt for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly short term debt is $2.65 M
What is Brainstorm Cell Therapeutics quarterly short term debt year-on-year change?
Over the past year, BCLI quarterly short term debt has changed by -$736.00 K (-56.36%)